Home
Live Updates
BiVictriX Therapeutics making cancer therapeutics exquisitely selective for target : comparemela.com
BiVictriX Therapeutics 'making cancer therapeutics exquisitely selective for target'
BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF)'s Chief executive Tiffany Thorn talks to Proactive London about their method and adding two potential cancer...
Related Keywords
London ,
City Of ,
United Kingdom ,
,
Bivictrix Therapeutics ,
Tiffany Thorn ,
Proactive London ,
comparemela.com © 2020. All Rights Reserved.